Contact Us

Welcome to is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.


Industry News


Scientific News



10.11.20 | Oystershell acquires Rid Brand

Oystershell has come to an agreement with Bayer HealthCare LLC to acquire RID®, one of the leading brands in lice treatment in the US. 

RID® is known for its strong consumer brand awareness, high levels of professional endorsement and its well-respected brand logo and attributes.  In 2019, RID® achieved 25 million USD in retail sales and is the #2 brand in the US lice treatment market.

10.11.20 | FDA Approve Sklice

The U.S. Food and Drug Administration has approved Sklice to treat head lice for nonprescription, or over-the-counter (OTC) use. The FDA initially approved Sklice (ivermectin) lotion, 0.5% for the treatment of head lice infestation in patients 6 months of age and older as a prescription drug in February 2012.

09.01.19 | Resultz Distributors appointed in Germany

Nuvo Pharmaceuticals have entered into an agreement with Heumann Pharma & Co GmBH Generica KC (Heumann) for the exclusive right to distribute, market and sell Resultz in Germany. Headquarterd in Nuremberg, Heumann is part of the Torrent Pharma Group.


A report by Jan Rainey published on April 29th 2018, suggests that NUVO PHARMACEUTICALS INC ORDINARY SHARES (OTCMKTS: NRIFF) had an increase of 1540% in short interest.

11.01.18 | Nuvo Pharmaceuticals acquires global rights for Head Lice Treatment

Nuvo Pharmaceuticals announced that it had acquired the global rights for Resultz, a head lice treatment from Piedmont Pharmaceuticals.

04.10.22 | AAP Guidance on Head Lice

The American Academy of Pediatrics has recently updated it's guidelines on head lice in schools.

The AAP indicates that head lice screening  programs in schools have not been proven to be particularly effective with a minimum impact on the incidence of head lice in schools. In addition, these programs are not value for money, and may stigmatize children suspected of having head lice. 



04.05.18 | Molecular Survey of Head and Body Lice, Pediculus humanus, in France

A new study has examined the genetic diversity of head and body lice collected from Bobigny, which is located near Paris (France), and confirmed for the first time the presence of clade E head lice in France. Clade E has upto this point been found mainly in lice from West Africa.

27.02.18 | Response of Pediculus humanus capitis to Volatiles of Whole and Individual Components of the Human Scalp

A new study has evaluated the response of head lice to volatiles that emanate from the human scalp, identifying the volatile components of the odor and the attractive or repellent activity of their pure main components.

11.01.18 | In vitro efficacy of five essential oils against Pediculus humanus capitis

A new study has assessed the in vitro efficacy of five essential oils against adults of Pediculus humanus capitis using a contact filter paper toxicity bioassay and revealed that Clove oil diluted either in coco oil or sunflower oil demonstrated the best adulticidal activity reaching over 90% within 2 hours in lice submitted to a 30 minute contact.

11.01.18 | The unusual reproductive system of head and body lice (Pediculus humanus)

A new study has conclusively established for the first time that both head and body lice reproduce through paternal genome elimination (PGE), an unusual genetic system in which males transmit only their maternally derived chromosomes.

morenews-ind.png morenews-sci.png
  • The world's only specialist website for the head lice industry
  • Scientific News
  • Regulatory News
  • Licecomb Engineering
  • Company News

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 — all rights reserved